nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Diabetic—Methotrexate—colon cancer	0.0336	0.0353	CcSEcCtD
Levobunolol—Stinging—Fluorouracil—colon cancer	0.0266	0.0279	CcSEcCtD
Levobunolol—Respiratory failure—Vincristine—colon cancer	0.0236	0.0247	CcSEcCtD
Levobunolol—Keratitis—Capecitabine—colon cancer	0.0233	0.0244	CcSEcCtD
Levobunolol—Timolol—ABCB1—colon cancer	0.0224	0.484	CrCbGaD
Levobunolol—Nadolol—ABCB1—colon cancer	0.0178	0.384	CrCbGaD
Levobunolol—Visual disturbance—Irinotecan—colon cancer	0.0173	0.0181	CcSEcCtD
Levobunolol—Cerebrovascular accident—Irinotecan—colon cancer	0.0167	0.0175	CcSEcCtD
Levobunolol—Lethargy—Fluorouracil—colon cancer	0.016	0.0168	CcSEcCtD
Levobunolol—Cardiac arrest—Vincristine—colon cancer	0.016	0.0167	CcSEcCtD
Levobunolol—Ataxia—Vincristine—colon cancer	0.0158	0.0166	CcSEcCtD
Levobunolol—Cardiac arrest—Irinotecan—colon cancer	0.0156	0.0163	CcSEcCtD
Levobunolol—Cardiac arrest—Fluorouracil—colon cancer	0.0149	0.0156	CcSEcCtD
Levobunolol—Ataxia—Fluorouracil—colon cancer	0.0147	0.0154	CcSEcCtD
Levobunolol—Erectile dysfunction—Vincristine—colon cancer	0.0134	0.014	CcSEcCtD
Levobunolol—Depression—Vincristine—colon cancer	0.0129	0.0135	CcSEcCtD
Levobunolol—Diabetes mellitus—Capecitabine—colon cancer	0.0126	0.0132	CcSEcCtD
Levobunolol—Conjunctivitis—Fluorouracil—colon cancer	0.0117	0.0123	CcSEcCtD
Levobunolol—Bradycardia—Irinotecan—colon cancer	0.0115	0.0121	CcSEcCtD
Levobunolol—Respiratory failure—Methotrexate—colon cancer	0.0114	0.012	CcSEcCtD
Levobunolol—Cerebrovascular accident—Capecitabine—colon cancer	0.0112	0.0117	CcSEcCtD
Levobunolol—Lethargy—Capecitabine—colon cancer	0.0112	0.0117	CcSEcCtD
Levobunolol—Diplopia—Capecitabine—colon cancer	0.0109	0.0115	CcSEcCtD
Levobunolol—Visual impairment—Irinotecan—colon cancer	0.0109	0.0114	CcSEcCtD
Levobunolol—Cardiac arrest—Capecitabine—colon cancer	0.0104	0.0109	CcSEcCtD
Levobunolol—Ataxia—Capecitabine—colon cancer	0.0103	0.0108	CcSEcCtD
Levobunolol—Alopecia—Vincristine—colon cancer	0.0103	0.0108	CcSEcCtD
Levobunolol—Arrhythmia—Irinotecan—colon cancer	0.0101	0.0106	CcSEcCtD
Levobunolol—Alopecia—Irinotecan—colon cancer	0.01	0.0105	CcSEcCtD
Levobunolol—Arrhythmia—Fluorouracil—colon cancer	0.00968	0.0102	CcSEcCtD
Levobunolol—Alopecia—Fluorouracil—colon cancer	0.00958	0.01	CcSEcCtD
Levobunolol—Diabetes mellitus—Methotrexate—colon cancer	0.00937	0.00983	CcSEcCtD
Levobunolol—Bronchospasm—Capecitabine—colon cancer	0.00931	0.00976	CcSEcCtD
Levobunolol—Syncope—Irinotecan—colon cancer	0.00883	0.00926	CcSEcCtD
Levobunolol—Loss of consciousness—Irinotecan—colon cancer	0.00866	0.00908	CcSEcCtD
Levobunolol—Visual disturbance—Methotrexate—colon cancer	0.0086	0.00902	CcSEcCtD
Levobunolol—Depression—Capecitabine—colon cancer	0.00841	0.00882	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00836	0.00877	CcSEcCtD
Levobunolol—Lethargy—Methotrexate—colon cancer	0.00832	0.00872	CcSEcCtD
Levobunolol—Cerebrovascular accident—Methotrexate—colon cancer	0.00832	0.00872	CcSEcCtD
Levobunolol—Conjunctivitis—Capecitabine—colon cancer	0.0082	0.0086	CcSEcCtD
Levobunolol—Confusional state—Irinotecan—colon cancer	0.00811	0.0085	CcSEcCtD
Levobunolol—Chest pain—Fluorouracil—colon cancer	0.00803	0.00842	CcSEcCtD
Levobunolol—Shock—Irinotecan—colon cancer	0.00791	0.00829	CcSEcCtD
Levobunolol—Confusional state—Fluorouracil—colon cancer	0.00776	0.00814	CcSEcCtD
Levobunolol—Hypotension—Vincristine—colon cancer	0.00771	0.00809	CcSEcCtD
Levobunolol—Bradycardia—Capecitabine—colon cancer	0.00771	0.00809	CcSEcCtD
Levobunolol—Ataxia—Methotrexate—colon cancer	0.00766	0.00804	CcSEcCtD
Levobunolol—Hypotension—Irinotecan—colon cancer	0.00751	0.00788	CcSEcCtD
Levobunolol—Paraesthesia—Vincristine—colon cancer	0.00741	0.00777	CcSEcCtD
Levobunolol—Visual impairment—Capecitabine—colon cancer	0.0073	0.00765	CcSEcCtD
Levobunolol—Paraesthesia—Irinotecan—colon cancer	0.00722	0.00757	CcSEcCtD
Levobunolol—Hypotension—Fluorouracil—colon cancer	0.0072	0.00755	CcSEcCtD
Levobunolol—Dyspnoea—Irinotecan—colon cancer	0.00717	0.00752	CcSEcCtD
Levobunolol—Erythema multiforme—Capecitabine—colon cancer	0.00716	0.00751	CcSEcCtD
Levobunolol—Pain—Vincristine—colon cancer	0.00706	0.0074	CcSEcCtD
Levobunolol—Paraesthesia—Fluorouracil—colon cancer	0.00691	0.00725	CcSEcCtD
Levobunolol—Pain—Irinotecan—colon cancer	0.00688	0.00721	CcSEcCtD
Levobunolol—Dyspnoea—Fluorouracil—colon cancer	0.00687	0.0072	CcSEcCtD
Levobunolol—Arrhythmia—Capecitabine—colon cancer	0.00677	0.0071	CcSEcCtD
Levobunolol—Alopecia—Capecitabine—colon cancer	0.00669	0.00702	CcSEcCtD
Levobunolol—Feeling abnormal—Irinotecan—colon cancer	0.00663	0.00695	CcSEcCtD
Levobunolol—Pain—Fluorouracil—colon cancer	0.00659	0.0069	CcSEcCtD
Levobunolol—Erectile dysfunction—Methotrexate—colon cancer	0.00649	0.0068	CcSEcCtD
Levobunolol—Feeling abnormal—Fluorouracil—colon cancer	0.00635	0.00665	CcSEcCtD
Levobunolol—Depression—Methotrexate—colon cancer	0.00626	0.00657	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00623	0.00653	CcSEcCtD
Levobunolol—Urticaria—Fluorouracil—colon cancer	0.00612	0.00641	CcSEcCtD
Levobunolol—Propranolol—ABCB1—colon cancer	0.00611	0.132	CrCbGaD
Levobunolol—Conjunctivitis—Methotrexate—colon cancer	0.00611	0.0064	CcSEcCtD
Levobunolol—Hypersensitivity—Vincristine—colon cancer	0.00608	0.00638	CcSEcCtD
Levobunolol—Hypersensitivity—Irinotecan—colon cancer	0.00592	0.00621	CcSEcCtD
Levobunolol—Asthenia—Vincristine—colon cancer	0.00592	0.00621	CcSEcCtD
Levobunolol—Syncope—Capecitabine—colon cancer	0.00591	0.0062	CcSEcCtD
Levobunolol—Palpitations—Capecitabine—colon cancer	0.00583	0.00611	CcSEcCtD
Levobunolol—Loss of consciousness—Capecitabine—colon cancer	0.0058	0.00608	CcSEcCtD
Levobunolol—Asthenia—Irinotecan—colon cancer	0.00577	0.00605	CcSEcCtD
Levobunolol—Hypersensitivity—Fluorouracil—colon cancer	0.00567	0.00595	CcSEcCtD
Levobunolol—Diarrhoea—Vincristine—colon cancer	0.00565	0.00592	CcSEcCtD
Levobunolol—Chest pain—Capecitabine—colon cancer	0.00561	0.00589	CcSEcCtD
Levobunolol—Diarrhoea—Irinotecan—colon cancer	0.0055	0.00577	CcSEcCtD
Levobunolol—Dizziness—Vincristine—colon cancer	0.00546	0.00572	CcSEcCtD
Levobunolol—Pruritus—Fluorouracil—colon cancer	0.00545	0.00571	CcSEcCtD
Levobunolol—Visual impairment—Methotrexate—colon cancer	0.00543	0.0057	CcSEcCtD
Levobunolol—Confusional state—Capecitabine—colon cancer	0.00543	0.00569	CcSEcCtD
Levobunolol—Erythema multiforme—Methotrexate—colon cancer	0.00533	0.00559	CcSEcCtD
Levobunolol—Dizziness—Irinotecan—colon cancer	0.00532	0.00558	CcSEcCtD
Levobunolol—Shock—Capecitabine—colon cancer	0.00529	0.00555	CcSEcCtD
Levobunolol—Diarrhoea—Fluorouracil—colon cancer	0.00527	0.00552	CcSEcCtD
Levobunolol—Headache—Vincristine—colon cancer	0.00517	0.00542	CcSEcCtD
Levobunolol—Dizziness—Fluorouracil—colon cancer	0.00509	0.00534	CcSEcCtD
Levobunolol—Headache—Irinotecan—colon cancer	0.00504	0.00528	CcSEcCtD
Levobunolol—Hypotension—Capecitabine—colon cancer	0.00503	0.00527	CcSEcCtD
Levobunolol—Alopecia—Methotrexate—colon cancer	0.00498	0.00522	CcSEcCtD
Levobunolol—Nausea—Vincristine—colon cancer	0.0049	0.00514	CcSEcCtD
Levobunolol—Paraesthesia—Capecitabine—colon cancer	0.00483	0.00507	CcSEcCtD
Levobunolol—Headache—Fluorouracil—colon cancer	0.00482	0.00506	CcSEcCtD
Levobunolol—Dyspnoea—Capecitabine—colon cancer	0.0048	0.00503	CcSEcCtD
Levobunolol—Nausea—Irinotecan—colon cancer	0.00478	0.00501	CcSEcCtD
Levobunolol—Pain—Capecitabine—colon cancer	0.0046	0.00483	CcSEcCtD
Levobunolol—Nausea—Fluorouracil—colon cancer	0.00457	0.0048	CcSEcCtD
Levobunolol—Feeling abnormal—Capecitabine—colon cancer	0.00443	0.00465	CcSEcCtD
Levobunolol—Urticaria—Capecitabine—colon cancer	0.00427	0.00448	CcSEcCtD
Levobunolol—Chest pain—Methotrexate—colon cancer	0.00418	0.00438	CcSEcCtD
Levobunolol—Confusional state—Methotrexate—colon cancer	0.00404	0.00424	CcSEcCtD
Levobunolol—Hypersensitivity—Capecitabine—colon cancer	0.00396	0.00416	CcSEcCtD
Levobunolol—Asthenia—Capecitabine—colon cancer	0.00386	0.00405	CcSEcCtD
Levobunolol—Pruritus—Capecitabine—colon cancer	0.00381	0.00399	CcSEcCtD
Levobunolol—Hypotension—Methotrexate—colon cancer	0.00374	0.00393	CcSEcCtD
Levobunolol—Diarrhoea—Capecitabine—colon cancer	0.00368	0.00386	CcSEcCtD
Levobunolol—Paraesthesia—Methotrexate—colon cancer	0.0036	0.00377	CcSEcCtD
Levobunolol—Dyspnoea—Methotrexate—colon cancer	0.00357	0.00374	CcSEcCtD
Levobunolol—Dizziness—Capecitabine—colon cancer	0.00356	0.00373	CcSEcCtD
Levobunolol—Pain—Methotrexate—colon cancer	0.00343	0.00359	CcSEcCtD
Levobunolol—Headache—Capecitabine—colon cancer	0.00337	0.00353	CcSEcCtD
Levobunolol—Feeling abnormal—Methotrexate—colon cancer	0.0033	0.00346	CcSEcCtD
Levobunolol—Nausea—Capecitabine—colon cancer	0.0032	0.00335	CcSEcCtD
Levobunolol—Urticaria—Methotrexate—colon cancer	0.00318	0.00334	CcSEcCtD
Levobunolol—Hypersensitivity—Methotrexate—colon cancer	0.00295	0.00309	CcSEcCtD
Levobunolol—Asthenia—Methotrexate—colon cancer	0.00287	0.00301	CcSEcCtD
Levobunolol—Pruritus—Methotrexate—colon cancer	0.00283	0.00297	CcSEcCtD
Levobunolol—Diarrhoea—Methotrexate—colon cancer	0.00274	0.00287	CcSEcCtD
Levobunolol—Dizziness—Methotrexate—colon cancer	0.00265	0.00278	CcSEcCtD
Levobunolol—Headache—Methotrexate—colon cancer	0.00251	0.00263	CcSEcCtD
Levobunolol—Nausea—Methotrexate—colon cancer	0.00238	0.0025	CcSEcCtD
